<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01918826</url>
  </required_header>
  <id_info>
    <org_study_id>11-AOI-06</org_study_id>
    <nct_id>NCT01918826</nct_id>
  </id_info>
  <brief_title>Evaluation of the Analgesic Efficiency of the Transcutaneous Neurostimulation in the Charcot Syndrome Marie Tooth on the Pains of Lower Limbs</brief_title>
  <official_title>Evaluation of the Analgesic Efficiency of the Transcutaneous Neurostimulation in the Charcot Syndrome Marie Tooth on the Pains of Lower Limbs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Charcot syndrome Marie Tooth is the most frequent hereditary neuromuscular diseases:&#xD;
      there is no curative treatment at present, on the other hand precautionary measures can be&#xD;
      taken (physiotherapy, port of splints, orthopaedic surgery and technical assistants). In the&#xD;
      literature and in our recent study (evaluation of the pain in the disease of CMT - Reference&#xD;
      center of the neuromuscular diseases - CHU Bow) the frequency of the pain is important&#xD;
      varying from 66 to 96 % cases, affecting especially hands and lower limbs. The care of the&#xD;
      pain in the Charcot syndrome Marie Tooth is not codified. The transcutaneous&#xD;
      neurostimulation(TENS) is a not medicinal and not invasive therapeutics, without any brought&#xD;
      back collateral effect, used at the same time in the chronic pain and acute since 1960, as&#xD;
      well for the neuropathic pains that musculo-scrawny. No study was realized this day on the&#xD;
      use of the TENS with analgesic aim in the CMT. We suggest studying the analgesic efficiency&#xD;
      of the TENS in the Charcot syndrome Marie Tooth on the pains of lower limbs, the most&#xD;
      frequent painful location in our recent works.&#xD;
&#xD;
      The main objective will be to analyze the improvement of the pain of lower limbs, based on&#xD;
      the decrease of the analogical visual scale(ladder) (EVA), at least 30 %.&#xD;
&#xD;
      The secondary objectives will be to estimate repercussions on the functional capacities (&#xD;
      ONLS), the quality of life (SF(sci-fi) 12), the satisfaction (EVA), the global&#xD;
      impression(printing) of change ( PGIC), the consumption of analgesic, DN4, NPSI (Neuropathic&#xD;
      Pain Symptom Inventory), Concise Questionnaire of the Pains ( QCD), HAD (Hospital Anxiety and&#xD;
      Depression scale).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>At 3 month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>CHARCOT MARIE TOOTH DISEASE</condition>
  <arm_group>
    <arm_group_label>TENS active</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NEUROSTIMULATION TRANSCUTANEE AIMED ANALGESIC ACTIVE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TENS placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>NEUROSTIMULATION TRANSCUTANEE AIMED ANALGESIC PLACEBO</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TENS</intervention_name>
    <arm_group_label>TENS active</arm_group_label>
    <arm_group_label>TENS placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age included between 18 and 75 years&#xD;
&#xD;
          -  Affected by CMT confirmed on clinical, family criteria, electrophysiological and / or&#xD;
             genetics&#xD;
&#xD;
          -  pain ≥ 3 months&#xD;
&#xD;
          -  EVA pain ≥ 4/10&#xD;
&#xD;
          -  patient having given his written consent and lit(enlightened)&#xD;
&#xD;
          -  patient susceptible to be followed regularly during at least 3 months&#xD;
&#xD;
          -  Patient member to the Social Security&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Expanding patients of associated neurological pathology&#xD;
&#xD;
          -  Patients having resorted to the TENS in the last 3 months&#xD;
&#xD;
          -  Medical history of cancers, collagen and quite other pathology which can interfere&#xD;
             with the experimental procedure&#xD;
&#xD;
          -  Patient carrier of a pacemaker or an active implantable medical device&#xD;
&#xD;
          -  Cutaneous hurt on the territory to be stimulated&#xD;
&#xD;
          -  Venous or arterial thrombosis or thrombophlebitis in the territory to be stimulated&#xD;
&#xD;
          -  Patient participant in another biomedical research on the pain or the period of&#xD;
             exclusion of which in a study is not ended&#xD;
&#xD;
          -  Patient under guardianship or deprived of all his liberties&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cécile RIBIERE</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nice</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cécile RIBIERE, Dr</last_name>
    <phone>04 92 03 55 05</phone>
    <email>ribiere.c@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile RIBIERE, Dr</last_name>
      <phone>04 92 03 55 05</phone>
      <email>ribiere.c@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile RIBIERE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <study_first_submitted>July 20, 2012</study_first_submitted>
  <study_first_submitted_qc>August 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2013</study_first_posted>
  <last_update_submitted>August 7, 2013</last_update_submitted>
  <last_update_submitted_qc>August 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth Diseases</mesh_term>
    <mesh_term>Charcot-Marie-Tooth Disease</mesh_term>
    <mesh_term>Nerve Compression Syndromes</mesh_term>
    <mesh_term>Hereditary Sensory and Motor Neuropathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

